Tag: elotuzumab

#VisualAbstract: Addition of elotuzumab to lenalidomide and dexamethasone did not significantly improve survival outcomes in newly diagnosed, transplant-ineligible multiple myeloma

byKathleen Lau

May 19, 2022

#VisualAbstract SWOG-1211: Addition of elotuzumab to RVd induction and maintenance (lenalidomide, bortezomib, dexamethasone) did not improve patient outcomes in untreated, high-risk multiple myeloma

byKathleen Lau

January 14, 2021

Phase III trial shows survival benefit for early multiple myeloma

Use of elotuzumab with conventional therapy linked to improved survival in multiple myeloma patients

byShaidah Deghan, MSc. MD

August 13, 2015

1. Adding elotuzumab to the conventional lenalidomide and dezamethasone was associated with a 30% reduction in the risk of disease ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result